Device Trial Radar · NCT07040150
Evaluation of a Novel Semi-Rigid Brace for Adolescent Idiopathic Scoliosis
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
60
Actual
Start
Dec 24, 2019
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Nippon Sigmax co., ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 27, 2025
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 10 years, up to 15 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Introduction: Spinal bracing remains the gold standard for conservative management of adolescent idiopathic scoliosis (AIS). However, poor adherence often limits treatment efficacy. The development of a brace that enhances compliance while maintaining sufficient corrective force is crucial. This study aimed to develop and evaluate the effectiveness of a novel semi-rigid brace for AIS based on wearing time and correction rate. Materials and Methods: The investigators enrolled patients who met the following Scoliosis Research Society (SRS) criteria for brace treatment: (1) confirmed AIS diagnosis, (2) Risser sign ≤ 2, (3) Cobb angle between 25° and 40°, (4) age ≥ 10 years, and (5) single-curve pattern. Wearing time was objectively measured over 180 days using embedded temperature sensors. Correction rates were assessed at initiation and after 180 days or more.
Conditions
- Adolescent Idiopathic Scoliosis (AIS)
Interventions
Spinal bracingDevice
The semi-rigid spinal brace was developed to enhance patient compliance while maintaining effective curve correction. Patients were instructed to wear the brace for 18-20 h daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Wearing timeTime frame: 180 days from registration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Aizu Medical Center at Fukushima Medical University
Aizu-Wakamatsu, Fukushima, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.